Myriam Golembo

Title: Myriam Golembo: Innovator in Chimeric Polypeptides

Introduction

Myriam Golembo is a notable inventor based in Moshav Netaim, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of chimeric polypeptides. Her innovative work has led to the filing of a patent that showcases her expertise and creativity in this specialized area.

Latest Patents

Myriam Golembo holds a patent for "Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same." This patent describes a plant-produced chimeric polypeptide that includes a TNF Alpha binding domain of a TNF receptor and an Fc domain of an immunoglobulin. The chimeric polypeptide is designed to specifically bind TNF Alpha, demonstrating its potential applications in therapeutic settings.

Career Highlights

Golembo is associated with Protalix Ltd., a company known for its innovative biopharmaceutical products. Her work at Protalix has allowed her to explore the practical applications of her research in the biotechnology industry. With her patent, she has positioned herself as a key player in the development of novel therapeutic agents.

Collaborations

Myriam Golembo has collaborated with esteemed colleagues such as Yoseph Shaaltiel and Uri Hanania. These partnerships have fostered a collaborative environment that enhances the research and development of innovative biotechnological solutions.

Conclusion

Myriam Golembo's contributions to the field of biotechnology, particularly through her patent on chimeric polypeptides, highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in science.